Examples include oral formulations of GnRH antagonists such as merigolix, elagolix, linzagolix, and relugolix, with the latter having significant efficacy in reducing heavy menstrual bleeding in women with fibroids and pelvic pain in women with endometriosis [103]. Here, GNRH1 is linked to leiomyoma.